99 related articles for article (PubMed ID: 19224049)
41. Knockdown of PEBP4 suppresses proliferation, migration and invasion of human breast cancer cells.
Wang SC; Zhou F; Zhou ZY; Hu Z; Chang L; Ma MD
Biomed Pharmacother; 2017 Jun; 90():659-664. PubMed ID: 28415045
[TBL] [Abstract][Full Text] [Related]
42. Non-conducting functions of potassium channels in cancer and neurological disease.
Sesti F; Bortolami A; Kathera-Ibarra EF
Curr Top Membr; 2023; 92():199-231. PubMed ID: 38007268
[TBL] [Abstract][Full Text] [Related]
43. Constitutive activation of delayed-rectifier potassium channels by a src family tyrosine kinase in Schwann cells.
Sobko A; Peretz A; Attali B
EMBO J; 1998 Aug; 17(16):4723-34. PubMed ID: 9707431
[TBL] [Abstract][Full Text] [Related]
44. CPEB4 promotes cell migration and invasion via upregulating Vimentin expression in breast cancer.
Lu R; Zhou Z; Yu W; Xia Y; Zhi X
Biochem Biophys Res Commun; 2017 Jul; 489(2):135-141. PubMed ID: 28536077
[TBL] [Abstract][Full Text] [Related]
45. Diversity of Potassium Channel Ligands: Focus on Scorpion Toxins.
Kuzmenkov AI; Grishin EV; Vassilevski AA
Biochemistry (Mosc); 2015 Dec; 80(13):1764-99. PubMed ID: 26878580
[TBL] [Abstract][Full Text] [Related]
46. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
Zuo Y; Wu Y; Chakraborty C
J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
[TBL] [Abstract][Full Text] [Related]
47. MiR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer.
Chen CP; Sun ZL; Lu X; Wu WX; Guo WL; Lu JJ; Han C; Huang JQ; Fang Y
Oncol Rep; 2016 Feb; 35(2):709-16. PubMed ID: 26573744
[TBL] [Abstract][Full Text] [Related]
48. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
49. Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer.
Song W; Li W; Li L; Zhang S; Yan X; Wen X; Zhang X; Tian H; Li A; Hu JF; Cui J
Oncotarget; 2015 Sep; 6(27):23764-75. PubMed ID: 26156017
[TBL] [Abstract][Full Text] [Related]
50. miR-130b-3p inhibits cell invasion and migration by targeting the Notch ligand Delta-like 1 in breast carcinoma.
Shui Y; Yu X; Duan R; Bao Q; Wu J; Yuan H; Ma C
Gene; 2017 Apr; 609():80-87. PubMed ID: 28163094
[TBL] [Abstract][Full Text] [Related]
51. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
52. Caveolin-1 limits the contribution of BKCa channel to MCF-7 breast cancer cell proliferation and invasion.
Du C; Chen L; Zhang H; Wang Z; Liu W; Xie X; Xie M
Int J Mol Sci; 2014 Nov; 15(11):20706-22. PubMed ID: 25397596
[TBL] [Abstract][Full Text] [Related]
53. Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.
Huo X; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Oncotarget; 2015 Dec; 6(39):41959-75. PubMed ID: 26544623
[TBL] [Abstract][Full Text] [Related]
54. Carvedilol suppresses migration and invasion of malignant breast cells by inactivating Src involving cAMP/PKA and PKCδ signaling pathway.
Dezong G; Zhongbing M; Qinye F; Zhigang Y
J Cancer Res Ther; 2014; 10(4):998-1003. PubMed ID: 25579542
[TBL] [Abstract][Full Text] [Related]
55. Potassium Channel Protein KCNK6 Promotes Breast Cancer Cell Proliferation, Invasion, and Migration.
Hou X; Tang L; Li X; Xiong F; Mo Y; Jiang X; Deng X; Peng M; Wu P; Zhao M; Ouyang J; Shi L; He Y; Yan Q; Zhang S; Gong Z; Li G; Zeng Z; Wang F; Guo C; Xiong W
Front Cell Dev Biol; 2021; 9():616784. PubMed ID: 34195184
[TBL] [Abstract][Full Text] [Related]
56. Integrins step up the pace of cell migration through polyamines and potassium channels.
Vandenberg CA
Proc Natl Acad Sci U S A; 2008 May; 105(20):7109-10. PubMed ID: 18480268
[No Abstract] [Full Text] [Related]
57. Metabolic control of K+ channels: an overview.
Latorre R
J Bioenerg Biomembr; 1991 Aug; 23(4):493-7. PubMed ID: 1917905
[No Abstract] [Full Text] [Related]
58. Introduction to breast disease review issue on metastasis.
Wakefield L; Hunter K
Breast Dis; 2006-2007; 26():1-2. PubMed ID: 17473361
[No Abstract] [Full Text] [Related]
59. What Is the Role of Potassium Channels in Ataxia?
Benarroch E
Neurology; 2021 Nov; 97(20):938-941. PubMed ID: 34782409
[No Abstract] [Full Text] [Related]
60. Editorial: Ion Channel Signalling in Cancer: From Molecular Mechanisms to Therapeutics.
Jiang LH; Adinolfi E; Roger S
Front Pharmacol; 2021; 12():711593. PubMed ID: 34149438
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
